SCHEMBL31740000

SCHEMBL31740000

CCCC(C)COc1ccc(CC(=O)OC)nc1

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GPR88 Q9GZN0 20/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25377756 0.81 GPR88 (0.51) GPR88
SCHEMBL15709788 0.81 MAPK1 (0.50) —
SCHEMBL31395578 0.79 MAPK1 (0.48) GPR88
SCHEMBL31395596 0.79 GPR88 (0.43) GPR88
SCHEMBL30106066 0.77 CYP11B1 (0.45) —
SCHEMBL15709873 0.75 MAPT (0.42) —
SCHEMBL9314216 0.75 SMN1; SMN2 (0.44) —
SCHEMBL15709957 0.74 MBOAT4 (0.42) —
SCHEMBL30106054 0.74 MBOAT4 (0.42) —
SCHEMBL3210022 0.74 NPC1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250367158-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 ACADIA PHARM INC (US) 2025-12-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250367158-A1 MODULATORS OF G PROTEIN-COUPLED RECEPTOR 88 GPR88, GPR68, HTR2A GPR88 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback